Mastboom Monique J L, Verspoor Floortje G M, Gelderblom Hans, van de Sande Michiel A J
Orthopaedic Surgery, Leiden University Medical Center, Leiden, Netherlands.
Orthopaedic Surgery, Radboud University Medical Center, Nijmegen, Netherlands.
Case Rep Orthop. 2017;2017:7402570. doi: 10.1155/2017/7402570. Epub 2017 Jun 28.
In Tenosynovial Giant Cell Tumours (TGCT), previously named Pigmented Villonodular Synovitis (PVNS), a distinction is made between a single nodule (localized-type) and multiple nodules (diffuse-type). Diffuse-type is considered locally aggressive. Onset and extermination of this orphan disease remain unclear. Surgical resection is the most commonly performed treatment. Unfortunately, recurrences often occur (up to 92%), necessitating reoperations and adjuvant treatments. Once all treatments fail or if severe complications occur, limb amputation may become unavoidable. We describe four cases of above-knee amputation after TGCT diagnosis.
在腱鞘巨细胞瘤(TGCT)中,以前称为色素沉着绒毛结节性滑膜炎(PVNS),可分为单个结节(局限性类型)和多个结节(弥漫性类型)。弥漫性类型被认为具有局部侵袭性。这种罕见疾病的发病和根除情况仍不清楚。手术切除是最常用的治疗方法。不幸的是,复发经常发生(高达92%),需要再次手术和辅助治疗。一旦所有治疗失败或出现严重并发症,肢体截肢可能不可避免。我们描述了4例腱鞘巨细胞瘤诊断后行膝上截肢的病例。